Expert outlines grim reality of MRI's dangers after man with 20-pound chain dies in machine mishap: ‘Snap his neck'
A 20-pound chain that Kevin McAllister was wearing around his neck would have been yanked into the machine at Nassau Open MRI with 'hundreds of pounds' of force, Dr. Emanuel Kanal told the Post on Tuesday.
'Even if he was standing there holding the chain in his hands, the strongest weightlifter would not be able to prevent this kind of an accident from happening,' said Kanal, director of Magnetic Resonance Service at the University of Pittsburgh Medical Center.
3 Keith McAllister, 61, suffered multiple heart attacks after he was sucked into an MRI machine by his 20-pound metal chain.
Facebook/Karim McAllister
'The problem is it's not a regular magnet, it's not a regular piece of iron. It's an unbelievably powerful magnet, and it's an unbelievably large piece of iron,' Kanal said, adding that the two factors resulted in 'hundreds of pounds of attraction in the direction of the magnet.'
McAllister was pinned to the machine for over an hour by the massive exercise chain fitted with a padlock that he wore when he was allegedly led into the machine room by an MRI technician to help his wife who was having her knee examined, his family said.
When he got 'within a few inches' of the machine, it could suddenly pull with 'such strength that it could have pulled sufficiently strongly to snap his neck,' Kanal said.
3 Family of McAllister claimed the 61-year-old was led into the machine room by a technician who did not tell the doting husband to remove his large metal chain.
Brigitte Stelzer
McAllister was pronounced dead at North Shore University Hospital the day after the bizarre accident with the cause being identified as three heart attacks, according to his family.
'[D]epending on the status of his health, he may have had problems with cardiovascular disease before, and when the excitement happened, he could have had a heart attack just from the event itself,' Kanal stated.
McAllister's wife described the haunting moments when her husband was breathing his last.
'His body went limp,' Adrienne Jones-McAllister told News 12 Long Island.
'He went limp in my arms and this is still pulsating in my brain,' she told the outlet through tears.
Despite decades in the medical industry, Kanal said the bizarre manner of death is incredibly rare.
3 The MRI machine could have pulled McAllister with enough force to snap his neck, an expert told The Post.
Brigitte Stelzer
'[It's] extremely rare that someone dies because of an interaction with a strong magnetic field — probably fewer than a dozen times since MRI first became a diagnostic tool in the early 1980s,' the expert stated.
His stepdaughter claimed the technician never warmed McAllister to take off the necklace that led to his demise.
'While my mother was laying on the table, the technician left the room to get her husband to help her off the table,' step-daughter Adrienne Jones-McAllister wrote in a GoFundMe.
'He forgot to inform him to take the chain he was wearing from around his neck off when the magnet sucked him in,' she wrote.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
5 hours ago
- Business Upturn
D-dimer Testing Market Size to Hit USD 2.74 Billion by 2032, Fueled by Rising Incidence of Thrombotic Disorders and Aging Population
Austin, Aug. 05, 2025 (GLOBE NEWSWIRE) — D-dimer Testing Market Size & Growth Analysis: According to SNS Insider, The D-dimer Testing Market was valued at USD 1.83 billion in 2023 and is projected to reach USD 2.74 billion by 2032, growing at a CAGR of 4.59% during the forecast period 2024–2032. The U.S. D-dimer Testing Market alone contributed USD 0.43 billion in 2023 and is projected to reach USD 0.59 billion by 2032, showcasing consistent demand in a region with a high prevalence of thrombotic and cardiovascular diseases. Get Free Sample Report of the D-dimer Testing Market: D-dimer testing is increasingly being adopted for its critical role in diagnosing deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). The rise in chronic conditions, aging global populations, and post-COVID-19 complications are expected to further fuel demand. Key Growth Drivers: Rising Prevalence of Thrombotic Events: Sedentary lifestyles, obesity, and smoking contribute to growing cases of DVT and PE. Aging Population: Older adults are more susceptible to clotting disorders, increasing demand for rapid diagnostic solutions. Point-of-Care Testing (POCT) Advances: Technological innovations are expanding test accessibility across outpatient and emergency care settings. Healthcare Infrastructure Expansion in Emerging Markets: Developing regions are investing in diagnostic technologies to improve patient outcomes. Major Players Analysis Listed in this Report are: Siemens Healthcare Biomedica Diagnostics Abbott Thermo Fisher Scientific Inc. WERFEN HORIBA, Ltd. SEKISUI Diagnostics F. Hoffmann-La Roche Ltd BIOMÉRIEUX QuidelOrtho Corporation Diazyme Laboratories Segment Analysis By Product: The market is led by the reagents & consumables segment in 2023, which held a share of 61.1% owing to its high-volume use for repetitive testing as well as rising demand for standardized product kits available at hospitals and laboratories. Test operation essential: Dynamic filling and dumping, consumables must be recycled frequently. By Test Type: Clinical laboratory tests held the majority share of 59.5% in 2023 on account of higher throughput and the fact that they can process bulk testing effectively, especially in hospitals & diagnostic centers. However, point-of-care tests (POCT) are experiencing the fastest growth owing to their rising application in the emergency department and outpatient care. A major driver is their potential to deliver fast, actionable results at the bedside or in ambulances. By Method: In 2023, the ELISA was responsible for a 39.6% market share driven by its proven efficiency and scalability to clinical lab settings with high accuracy levels. The latex-enhanced immunoturbidimetric assay is a rapidly expanding method with a shorter turnaround time and full integration into automated analyzers, which allows rapid high-throughput testing. By Application: The highest DVT market share was for the deep vein thrombosis (DVT) segment in 2023, with a global spread and significant clinical emphasis on its early detection. Pulmonary embolism (PE) is turning out to be the fastest growing segment, and this growth is particularly attributed to an increase in awareness as well as advancements in detection technologies across emergency medicine. By End-Use: Hospitals controlled the largest share of the market in 2023, at 32.8%. This occurs because of the large number of emergency, ICU, and in-house laboratories capable of carrying out rapid diagnostic work-ups. For a Personalized Briefing with Our Industry Analysts, Connect Now: D-dimer Testing Market Segmentation By Product Analyzers Reagents & Consumables By Test Type Clinical Laboratory Tests Point-of-Care Tests By Method Enzyme-linked Immunosorbent Assay (ELISA) Latex-enhanced Immunoturbidimetric Assays Fluorescence Immunoassays Others By Application Deep Vein Thrombosis (DVT) Pulmonary Embolism (PE) Disseminated Intravascular Coagulation (DIC) Others By End-Use Hospitals Academic & Research Institutes Diagnostic Centers Others Regional Analysis The market in North America is expected to grow at the highest CAGR during the forecast period, driven by high healthcare expenditure, strong laboratory testing base, and a well-developed physician network. The U.S., especially, has high diagnostic rates and cardiovascular disease incidence, thus ruling the region. Asia Pacific is the largest growing region for the anticipated period. The diagnostic field is experiencing an exponential growth in several countries, such as China and India, driven by escalating investments toward healthcare infrastructure development and growing accessibility to POCT products. Several drivers contribute to RT acceptance: heightened public awareness, wider insurance coverage, and government moves against noncommunicable disease. Recent Advances in D-dimer Testing Market Feb 2023 – Carolina Liquid Chemistries Corp. and Diazyme Laboratories added D-dimer to its test menu on the DZ-Lite c270 analyzer, part of a batch of 25 new assays to give diagnosticians more flexibility. April 2024 – Siemens Healthineers introduced an enhanced D-dimer assay to the Atellica Solution platform, which provided enhanced sensitivity and turnaround times for emergency settings. Suggested Unique USP Sections for Client Proposal Prevalence-Based Demand Modeling – Country-wise mapping of thrombotic disease burden vs. current D-dimer testing rates. – Country-wise mapping of thrombotic disease burden vs. current D-dimer testing rates. Point-of-Care Ecosystem Analysis – Mapping adoption trends and infrastructure requirements for POCT expansion across regions. – Mapping adoption trends and infrastructure requirements for POCT expansion across regions. Regulatory & Reimbursement Landscape – Coverage policies, regional regulatory hurdles, and HTA frameworks impacting test adoption. – Coverage policies, regional regulatory hurdles, and HTA frameworks impacting test adoption. AI Integration & Diagnostic Decision Support – Innovations around AI-enhanced interpretation of D-dimer results for clinical triage. – Innovations around AI-enhanced interpretation of D-dimer results for clinical triage. Hospital-Laboratory Partnership Models – Case studies on how labs and hospitals are optimizing diagnostic turnaround and cost via partnerships. – Case studies on how labs and hospitals are optimizing diagnostic turnaround and cost via partnerships. Workflow & Automation Impact Analysis – Efficiency benchmarking of automated platforms vs. manual processing for D-dimer testing. – Efficiency benchmarking of automated platforms vs. manual processing for D-dimer testing. D-dimer in Multi-Analyte Panels – Future scope and pipeline analysis of D-dimer integration into cardiovascular or coagulation biomarker panels. Buy the Full D-dimer Testing Market Report (Single-User License) Now: About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
New York Post
20 hours ago
- New York Post
OF COURSE New York's bungled weed legalization fueled a wave of addiction
An explosive Post exclusive revealing that legal weed is fueling a wave of addiction is fresh proof of Albany's feckless legalization. 'It's one of the stupidest things our society has done — they legalized cannabis during the opioid crisis,' grumbled Luke Nasta, president and CEO of Camelot Counseling of Staten Island. Thing is, neither the Legislature's leaders nor Gov. Andrew Cuomo (then eyeing a 2020 presidential run) cared about the risks, the clear downsides or even elementary practicality when they rammed through legalization in 2019. Advertisement They let social-justice obsessions write the new rules, then installed a clueless crew to run the new state Office of Cannabis Management. As the OCM dithered over awarding the new licenses, illegal shops popped up all over the city and state — shielded from law enforcement by the new laws' lunatic provisions. So the outlets that had proven their ability by selling under the 2014 medical-marijuana law got crushed even as qualified new potential sellers couldn't open for business. Advertisement Oh, and Albany didn't even allow for common-sense limits on smoking dope in public, so the reek of weed is everywhere. Worst of all, the politicians shut their ears to warnings about the impact of cannabis on young brains — a prime reason the Medical Society of New York opposed legalization. So the state saw an explosion of flavored weed products and edibles, plainly aimed at hooking young people susceptible to addiction. Get opinions and commentary from our columnists Subscribe to our daily Post Opinion newsletter! Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters Advertisement Any legalization risked bringing an avalanche of new addicts, but New York's move might as well have been timed and designed to maximize the damage. How mad does it get? Consider the nonprofit Housing Works, which runs drug-treatment services and a cannabis-dispensary arm. It tells its pot customers they're 'helping fund lifesaving services that support thousands of New Yorkers each year' — except that its treatment centers on the addict-enabling 'harm reduction' approach. Prospering by feeding misery: That's pretty much the essence of Albany's approach to legalization.
New York Post
a day ago
- New York Post
TruSkin serum works harder than your ex ever did — oh and it's 56% off
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. In this gilded jungle of serums with price tags that sound more like rent payments than skincare staples, finding a $20 bottle that doesn't ghost you after three uses feels like swiping right on someone who not only texts back but also shows up — on time, moisturized, and maybe even with a dog and a home upstate. TruSkin's Vitamin C Serum, a two-ounce glow potion the Post has long-time adored — with over 150,000 outstanding Amazon reviews and a cult following that speaks for itself. Let's be real: This serum isn't that flashy. The bottle doesn't necessarily win many minimalist design points, and it doesn't pretend its ingredients were hand-foraged at sunrise on a Himalayan cliff. What it does have is a straight-talking trio of Vitamin C, Hyaluronic Acid, and Vitamin E. A powerhouse blend that politely tells dark spots and fine lines, 'It's closing time'. Think of it as the Olivia Pope of skincare: handles crises (sun damage, hyperpigmentation, laugh lines that aren't very funny), leaves no trace, and works best when layered under SPF and a fun-flavored latte. I've shelled out for serums that arrived in velvet boxes and smelled like regret. I've bought into creams that needed a mini spatula and a prayer to apply. Most of them left me with nothing but an overdrafted bank account and a faint scent of lavender. But TruSkin? It's refreshingly low-maintenance, wildly dependable, and gives your face that rested, radiant look (no spa weekend or Facetune required). Bonus: It's cruelty-free, vegan, and suspiciously unscented, which, for skincare aficionados, is like finding a New York apartment with no broker's fee and an in-unit washer-dryer. If your face is looking like a map of the MTA lines, dark zones, and a general sense of chaos, this serum is your express train to smoother, brighter, 'I woke up like this' territory. Just don't be surprised if people start asking for your skincare routine…or your ID. For over 200 years, the New York Post has been America's go-to source for bold news, engaging stories, in-depth reporting, and now, insightful shopping guidance. We're not just thorough reporters – we sift through mountains of information, test and compare products, and consult experts on any topics we aren't already schooled specialists in to deliver useful, realistic product recommendations based on our extensive and hands-on analysis. Here at The Post, we're known for being brutally honest – we clearly label partnership content, and whether we receive anything from affiliate links, so you always know where we stand. We routinely update content to reflect current research and expert advice, provide context (and wit) and ensure our links work. Please note that deals can expire, and all prices are subject to change.
